Delivery Order SPE2DR25D1106-SPE2DR26FJA8K
Award Date 11/24/25
Potential Completion Date 11/25/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $14,829.77 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 mL syringes on September 24, 2025, with completion expected by September 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Monovisc is a viscosupplement injection used in orthopedic and rheumatological...
- The Defense Logistics Agency awarded a $2,194.02 delivery order to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 mL syringes on August 15, 2025, with an ultimate completion date of August 18, 2025. This is a firm fixed price, non-set-aside contract performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX),...
- The Defense Logistics Agency awarded a $6,814.56 delivery order to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 mL syringes on December 5, 2025, with completion targeted for December 8, 2025. This competitively awarded, firm fixed-price delivery order represents a routine pharmaceutical supply transaction processed through the company's existing contract vehicle with DLA. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,962.22 to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 mL syringes on September 5, 2025, with completion targeted for September 8, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Monovisc is a viscosupplement injection used to treat osteoarthritis pain, representing one of the specialized...
- The Defense Logistics Agency awarded a delivery order valued at $4,819.92 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 ml syringes on August 27, 2025, with completion scheduled for August 28, 2025. This non-competitive, firm fixed-price delivery order represents a single procurement under AmerisourceBergen's larger contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency awarded a delivery order valued at $8,866.94 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 ml syringes on August 25, 2025, with a completion date of August 26, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, executed through competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Monovisc is...
- The Defense Logistics Agency awarded a $1,204.98 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Monovisc 88 mg/4 mL syringes. This is a non-set-aside contract with an ultimate completion date of September 23, 2025, and performance to be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order leverages AmerisourceBergen's existing Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $14,155.08 on July 18, 2025, for the supply of Monovisc 88 mg/4 mL syringes through the Defense Logistics Agency Medical Supply Chain. The contract represents a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and involves no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Monovisc is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Monovisc 88 mg/4 mL syringes with a ceiling value of $2,885.57. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract specifies an ultimate completion date of October 17, 2025, and identifies Conshohocken, Pennsylvania as the place of performance, which is also the location of...
- The Defense Logistics Agency awarded a delivery order valued at $9,089.29 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 mL syringes on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Monovisc is a hyaluronic acid-based joint injection used primarily for osteoarthritis pain...